Splenectomy in Hematologic Disorders
- 8 June 1972
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 286 (23) , 1252-1254
- https://doi.org/10.1056/nejm197206082862307
Abstract
DURING the past sixty years splenectomy (Sx) has become a common procedure for the treatment of hypersplenism. Hypersplenism is a hematologic term describing premature destruction of blood cells by the spleen, usually with consequent anemia or leukocytopenia or thrombocytopenia — or all three. Dameshek established four signs of hypersplenism, the tetralogy consisting of cytopenia of the blood, corresponding hyperplasia of the precursor tissue in the bone marrow (e.g., thrombocytopenia with increased megakaryocytes), splenomegaly and — the clincher — cure of the cytopenia after Sx. There are exceptions to the first three rules. For example, in hereditary spherocytosis (HS) the red-cell . . .Keywords
This publication has 6 references indexed in Scilit:
- Splenectomy in Patients with LymphosarcomaBMJ, 1971
- The Pathologic Anatomy of the Splenic Red PulpPublished by Springer Nature ,1970
- Agnogenic Myeloid MetaplasiaArchives of internal medicine (1960), 1967
- Idiopathic acquired autoimmune hemolytic anemiaThe American Journal of Medicine, 1967
- Splenectomy in the ElderlyMedical Clinics of North America, 1966
- HypersplenismAnnual Review of Medicine, 1962